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Superoxide r lease from human neutrophils was stimulated either by receptor activation (using fMet-Leu- 
Phe) or by activating, independently, each of the two pathways considered to be involved in signal transduc- 
tion - calcium mobilization (using the ionophore, A23 187) and protein kinase C activation (using phorbol 
myristate acetate or I-oleoyl-2-acetylglycerol). Prostaglandin E, (3 x 10ms M) decreased &let-Leu-Phe-stim- 
mated superoxide release, had no effect on superoxide release stimulated by A23 187, or by phorbol myri- 
state acetate, and markedly enhanced the superoxide release stimulated by I-oleoyl-2-acetylglycerol. Similar 
enhancement was obtained with prostaglandin E,. 
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1. INTRODUCTION 
Neutrophils, when activated by soluble 
stimulants or during phagocytosis, as occurs in 
areas of inflammation, manifest an increased up- 
take of 02 and generate substantial amounts of 
superoxide (OF), hydrogen peroxide and other 02 
products. This process is important in oxygen- 
dependent microbial killing (review [1]) and may 
also be implicated in cell and tissue damage [2]. 
However, as has been emphasized in a recent 
review [3], the events involved in stimulus- 
activation coupling for the respiratory burst are 
not yet fully understood. 
Prostaglandins Er and Ez, which are thought to 
be produced in inflammatory reactions, have been 
reported to inhibit superoxide release from 
neutrophils when the stimulus is fMet-Leu-Phe 
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[4-61, but not when the stimulus is PMA [5,6]. 
The effect of these prostaglandins correlates with 
an increase of cyclic AMP [4,6] but the site of ac- 
tion of these agents on the transduction 
mechanism is not known. 
It has recently been postulated that in many 
cells, two pathways may be involved in receptor- 
mediated signal transduction: (i) the generation of 
diacylglycerol which activates protein kinase C, 
and (ii) an increase in cytosolic calcium - both 
pathways being initiated, possibly, by the 
breakdown of polyphosphoinositides (review, 
[7,8]). Some evidence that the model proposed 
may be applicable to signal transduction by fMet- 
Leu-Phe in neutrophils has been reported [9-121. 
Each pathway can be independently activated - 
the calcium pathway by a calcium ionophore, such 
as A23187, and the protein kinase C pathway by 
either PMA or OAG, which can substitute for en- 
dogenous diacylglycerol (review, [7]). Evidence 
that both pathways may be involved in 0; genera- 
tion in neutrophils has recently been provided, us- 
ing, as the protein kinase C activator, PMA 
[13-151 or OAG [16]. Here, we compared the ef- 
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feet of PGEi on Or generation produced by recep- 
tor activation (using fMet-Leu-Phe) with Or 
generation produced by activating, independently, 
each of the pathways specified above. We report 
that PGEz had different effects in each case and 
the results might provide a clue as to its site of ac- 
tion in stimulus-activation coupling. 
2OOr o 6 
2. MATERIALS AND METHODS FMLP OAG A23187 PMA 
Neutrophils were collected from human 
volunteers by venipuncture, and prepared as in 
[ 151. The cells were equilibrated for 20 min at 
37°C; those cells which were to be stimulated 
either by FMLP or A23187 were incubated with 
cytochalasin B (lOpg/ml) for a further 10 min. 
Following this, 2.5 x lo6 cells were dispensed into 
2.5 ml tubes (Sterilin, NA2S) to which had been 
added 1 mg ferricytochrome c (horse heart type 
III, Sigma), appropriate dilutions of the stimulant 
(FMLP, OAG, A23187 or PMA), 3 x 10e5 M 
PGEi (or Tyrode solution, in control tubes) and 
either Tyrode solution or 75 units superoxide 
dismutase (bovine blood, Sigma). The final 
calcium concentration in all samples was 3 mM. 
After 30 min incubation at 37”C, the reaction was 
stopped and the amount of 0: generated measured 
as in [15]. All reagents were obtained from Sigma, 
except OAG which was synthesized by Dr A. 
Watts, Biochemistry Department, University of 
Oxford, England. 
aor b 
3. RESULTS 
In 4 experiments, PGEi (3 x 1O-5 M) markedly 
reduced the 02 release stimulated by lo-’ M fMet- 
Leu-Phe (fig.la). The difference between the test 
readings (with PGEr) and control readings was 
statistically significant at the level p = 0.01 on a 
paired-sample t-test. PGEz had a similar effect 
(not shown). 
OAG A23187 
Fig.1. (a) The effect of PGEr, 3 x lO-5 M, on the 
stimulation of superoxide release by submaximal 
concentrations of stimulants: fMet-Leu-Phe (lo-’ M), 
OAG (30 or 50 fig/ml), A23187 (5 x lO-5 M) and PMA 
(10 ng/ml). The data are expressed as the percentage of 
control values (i.e., in the absence of PGEt). The 
number of experiments with each stimulus is given above 
the columns. The mean control 0~ release at the 
concentrations specified was 36.2 k 2.6 nmol per 5 x 10” 
cells with fMet-Leu-Phe, 28.4 + 3.7 with OAG, 22.0 +_ 
9.7 with A23187 and 59.6 + 40 with PMA. (b) The dose- 
response curve of 02 release with OAG &g/ml), in the 
absence (0) and presence (m) of PGEz (3 x lO-5 M). (c) 
The dose-response curve of 0: release with A23187 (M), 
in the absence (0) and presence (+) of PGEr (3 x 
lo-’ M). 
was investigated, the curve was not only shifted to 
the left in the presence of PGEi, but the maximum 
response was increased. A similar result was ob- 
tained with PGE2 (shown in fig.lb). 
With OAG maximum 0; release was obtained Seven experiments were carried out with PMA 
at a concentration of either 50 or 100 &g/ml. In 6 over a concentration range l-50 ng/ml, maximum 
experiments, PGEi (3 x lo-’ M) markedly responses being obtained at 20-50 ng/ml in dif- 
enhanced submaximal superoxide release stimu- ferent experiments. In several experiments PGEi 
lated by a submaximal concentration of OAG, (3 x 10F5 M) caused an increase, sometimes 
either 30 or 50 pg/ml (fig. la), the difference be- marked, in 0; release with low concentrations of 
tween test and control readings being significant at PMA, but the differences between test and control 
p = 0.001 on a paired-sample t-test. In 3 out of the readings were not statistically significant at the 
5 experiments in which the full dose-response curve level p = 0.05 in a paired-sample t-test. The results 
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with a submaximal concentration of PMA, 
10 ng/ml, are shown in fig.la. 
In 7 experiments, PGEr (3 x 10m5 M) had no 
significant effect on the stimulation of superoxide 
release by A23187 (5 x lo-’ M) (fig.la,c). 
4. DISCUSSION 
It is usually considered that the inhibitory action 
of prostaglandins uch as PGEl, PGEz and PGI2 
on Ot generation by neutrophils is produced main- 
ly by increasing cyclic AMP [4,6]. It has been 
pointed out that these prostaglandins inhibit fMet- 
Leu-Phe-stimulated 0; release but not PMA- 
stimulated 02 release [5,6] and it has been sug- 
gested that the inhibition is due to modulation of 
calcium-dependent events (61. There is also 
evidence for a mechanism of action involving a 
decrease in affinity of the formyl peptide receptor 
[17]. In this study, PGEr did not have any signifi- 
cant effect on A23187-stimulated 02 release, 
which could imply that it does not have much ef- 
fect on calcium-dependent events. 
A tentative hypothesis, based on the model of 
signal-transduction outlined in [7], which could ex- 
plain the results obtained in this study with all four 
agents, would be that PGEi and PGE2 modify the 
turnover of polyphosphoinositides by decreasing 
the conversion of DAG to phosphatidic acid 
through an action on DAG kinase. OAG is 
metabolized rapidly in situ, to its corresponding 
phosphatidic acid [7], presumably by DAG kinase. 
An inhibitory action on this enzyme would result 
in high, maintained concentrations of OAG and 
thus enhanced OAG responses. It would also 
decrease the effect of fMet-Leu-Phe by decreasing 
the availability of phosphatidylinositol biphos- 
phate. The calcium pathway would be affected at 
a point prior to the rise in cytosolic calcium (i.e., 
by inhibition of production of inositol triphos- 
phate) and thus there would be no effect on the 
response to ionophore-induced increase in cyto- 
solic calcium. 
PMA is metabolised very slowly [18]; neither its 
metabolism nor its effect should be affected by 
agents which modify inositol lipid turnover. 
It has been shown, for platelets (see [7]) and 
lymphocytes [19] that PGEi inhibits signal- 
induction of both cell-activation and turnover of 
inositol phospholipids, the mechanism being 
thought to involve an increase in cyclic AMP. Fur- 
thermore, it has been reported that, in neutrophils, 
dibutyryl cyclic AMP selectively inhibits 32Pi ncor- 
poration into phosphatidic acid [20]. There is 
evidence that, in platelets, the effect of increased 
cyclic AMP is, in large part, due to an action on 
phospholipase C [21,22]. However, the effect in 
platelets is clearly different from that in 
neutrophils in that a signal-induced increase in 
cyclic AMP in platelets is also associated with a 
marked reduction in the concomitant increase in 
Ca2+ [23] whereas in neutrophils this is not the case 
i241. 
Stimulation of neutrophils with fMet-Leu-Phe 
has been reported to result in an increase of DAG 
in one study [25] but in another [26] it has been 
suggested that this may not occur. If this latter 
statement is correct, an explanation other than the 
one proposed here would be required for the PGEi 
effect on 0; generation by neutrophils stimulated 
with this peptide. 
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